Remove 2020 Remove Healthcare Provider Remove Pharmacology
article thumbnail

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases. The aim of the programme is to expedite the development, assessment and review of medical devices in order to provide timely access to patients and healthcare providers.

article thumbnail

Understanding a rare disease through the lens of real world and prevalence data

Clarivate

In recent years, we’ve seen an increase in awareness among healthcare providers and better diagnosis of rare diseases, leading to improved access to care for patients with these uncommon conditions. 4; 4/20/2020; DOI:10.7759/cureus.7745 ” Molecular Vision; 12/28/2020; p789 [5] Sahel J et al. ” Cureus; V.12;

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Real-World Evidence (RWE) Real-word data from electronic health records, insurance claims, wearables, social media, and other sources can provide important insights into real-life drug performance, patient adherence, and market trends to inform better decision-making.

Pharma 92
article thumbnail

Pharmacodynamics and Pharmacokinetics: The Science Behind Drug Action (Understanding the different characteristics of a drug and how they are important for therapeutic success)

Pharmaceutical Representative Training

For sales representatives, the PRC and CSPP certifications can enhance this understanding and communication with HCPs: Pharmaceutical Representative Certification (PRC) : This certification provides professionals with a foundational knowledge of pharmacology, regulatory standards, and effective communication strategies. link] Rang, H.

article thumbnail

The Role of Certified Pharmaceutical Representatives in the Shifting Sales Landscape

Pharmaceutical Representative Training

Case Summary: In 2020, this company agreed to pay $678 million to settle allegations that it violated the False Claims Act by paying kickbacks to doctors. The Department of Justice (DOJ) accused this company of providing lavish meals, entertainment, and speaker fees to healthcare providers (HCPs) to induce them to prescribe their drugs.

Sales 52